Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Promega Corp v. Life Tech
Case Number:
13-1011
Court:
Nature of Suit:
830 Patent Infringement (Fed. Question)
Companies
Sectors & Industries:
-
January 30, 2018
Life Tech Rips Promega Bid To Rethink US Damages In IP Row
Life Technologies Corp. on Monday urged the Federal Circuit to uphold its finding that Promega Corp. doesn't deserve U.S.-specific damages in patent litigation over genetic-testing kits, despite pleas from Promega for a rehearing before the full court.
-
February 27, 2015
Fed. Circ. Won't Rehear Promega, Life Tech IP Dispute
The Federal Circuit shot down on Thursday dueling petitions by Promega Corp. and Life Technologies Corp., which each sought to have the appellate court review its ruling that reversed an order vacating Promega's $52 million win in a patent and licensing dispute over gene-testing technology.
-
January 16, 2015
Promega, Life Tech Both Urge Fed. Circ. To Review IP Ruling
Promega Corp. and Life Technologies Corp. have lodged dueling petitions each urging the Federal Circuit on Wednesday to review portions of its decision to undo a federal judge's order vacating Promega's $52 million patent win over the alleged infringement of its gene-testing technology while still invalidating all but one of Promega's asserted patents.
-
December 15, 2014
Fed. Circ. Gives Promega 2nd Shot In $52M LifeTech IP Fight
A Federal Circuit panel paved the way Monday for Promega Corp. to collect some damages from Life Technologies Corp. over infringement of its gene-testing technology, reversing an order vacating Promega's $52 million patent win and ruling Life Technologies was liable for inducing infringement even without a third party's involvement.